Same-day angioplasty feasible, safe

Patel M, Kim M, Karajgikar R, et al. Outcomes of patients discharged the same day following percutaneous coronary intervention. JACC Cardiovascular Interventions 2010; 3:851-8.

Chambers CE, Dehmer GJ, Cox DA, et al. Defining the length of stay following percutaneous coronary intervention: an expert consensus document from the Society for Cardiovascular Angiography and Interventions. Endorsed by the American College of Cardiology Foundation. Catheterization and Cardiovascular Interventions 2009; 73:847-58.

Long-term look at aneurysm repair

Schermerhorn ML, O'Malley AJ, Jhaveri A, Cotterill P, Pomposelli F, Landon BE. Endovascular vs. open repair of abdominal aortic aneurysms in the Medicare population. New England Journal of Medicine 2008; 358:464-74.

Giles KA, Landon BE, Cotterill P, O'Malley AJ, Pomposelli FB, Schermerhorn ML. Thirty-day mortality and late survival with reinterventions and readmissions after open and endovascular aortic aneurysm repair in Medicare beneficiaries. Journal of Vascular Surgery 2011; 53:6-12,13 e1.

Study suggests caution on statins after a bleeding stroke

Amarenco P, Bogousslavsky J, Callahan A, 3rd, et al. High-dose atorvastatin after stroke or transient ischemic attack. New England Journal of Medicine 2006; 355:549-59.

Westover MB, Bianchi MT, Eckman MH, Greenberg SM. Statin Use Following Intracerebral Hemorrhage: A Decision Analysis. Archives of Neurology 2011; published online, Jan. 10, 2011.

Hypertrophic cardiomyopathy: Optimism tinged with caution

Ho CY. Genetics and clinical destiny: improving care in hypertrophic cardiomyopathy. Circulation 2010; 122:2430-40; discussion 2440.

Ho CY, Lopez B, Coelho-Filho OR, et al. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. New England Journal of Medicine 2010; 363:552-63.

Barry J. Maron and Lisa Salberg. Hypertrophic Cardiomyopathy: For Patients, Their Families and Interested Physicians (Wiley-Blackwell, 2006)

Kidney trouble and warfarin

Limdi NA, Limdi MA, Cavallari L, et al. Warfarin dosing in patients with impaired kidney function. American Journal of Kidney Diseases 2010; 56:823-31.

Breast cancer drugs and heart risk

Amir E, Oca�a A, Niraula S, Carlsson L, Seruga B. Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients. Presented at the 33rd annual San Antonio Breast Cancer Symposium in San Antonio, TX on Dec. 9, 2010.

Family matters: Your parents' heart health affects yours

Chow CK, Islam S, Bautista L, et al. Parental history and myocardial infarction risk across the world: the INTERHEART Study. Journal of the American College of Cardiology 2011; 57:619-27.

In Brief

Marathons hard on the heart: Gaudreault V, Tiz�n-Marcos H, Poirier P, Gilbert P, Amyot M, Rod�s-Cabau J, Bertrand O, Larose �. Transient myocardial injury, microvascular dysfunction and decreased segmental function in less fit recreational marathon runners. Canadian Journal of Cardiology 2010; 26(Suppl D)

Kidney trouble and warfarin: Limdi NA, Limdi MA, Cavallari L, et al. Warfarin dosing in patients with impaired kidney function. American Journal of Kidney Diseases 2010; 56:823-31.

Breast cancer drugs and heart risk: Amir E, Oca�a A, Niraula S, Carlsson L, Seruga B. Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients. San Antonio Breast Cancer Symposium 2010; abstract online